Economic evaluation of dabigatran etexilate for the prevention of venous thromboembolism in patients aged over 75 years or with moderate renal impairment undergoing total knee or hip replacement
Autoren
Wolowacz SE, Roskell NS, Plumb JM, Clemens A, Noack H, Robinson PA, Dolan G, Brenkel IJ
Journal
Thromb Haemostasis
Veröffentlichungsdatum
2009
Impact Factor
6.094
Abstract
Weitere IDs
Economic evaluation of dabigatran etexilate for the prevention of venous thromboembolism in patients aged over 75 years or with moderate renal impairment undergoing total knee or hip replacement - Publikation von Dr. Andreas Clemens | Dr. Andreas Clemens